![]() |
产地 | 中国 |
品牌 | Chemstan |
保存条件 | |
货号 | CS021016 |
用途 | 科研用途 |
应用范围 | Research Grade Biosimilar |
抗原来源 | |
保质期 | |
抗体名 | Research Grade Ozanezumab |
是否单克隆 | |
克隆性 | |
靶点 | |
适应物种 | Human |
形态 | Liquid |
宿主 | Humanized |
标记物 | |
包装规格 | 100ug |
亚型 | IgG1-nd |
标识物 | |
浓度 | 95% |
免疫原 | |
是否进口 | 否 |
Catalog No.
CS021016
Species reactivity
Human
Applications
Research Grade Biosimilar
Host species
Humanized
Isotype
IgG1-nd
Expression system
Mammalian Cells
Clonality
Monoclonal
Target
RTN-x, Reticulon-4, Neuroendocrine-specific protein, Neuroendocrine-specific protein C homolog, NOGO, Nogo protein, Neurite outgrowth inhibitor, NSP, Reticulon-5, KIAA0886, RTN4, Foocen
Concentration
1mg/ml
Endotoxin level
Please contact the lab for this information.
Purity
>95% purity as determined by SDS-PAGE.
Purification
Protein A/G, purified from cell culture supernatant.
Accession
Q9NQC3
Form
Liquid
Storage buffer
0.01M PBS,pH7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -376°C.
Alternate Names
GSK-1223249,CAS:1310680-64-8
Background
Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research.
Note
For research use only. Not for use in clinical or therapeutic applications.